The largest database of trusted experimental protocols

8 protocols using caco 2

1

Caco-2 Cell Culture as Intestinal Model

Check if the same lab product or an alternative is used in the 5 most similar protocols
The human colon cancer cell line Caco-2 (RIKEN Cell Bank, Tsukuba, Japan) spontaneously differentiates into an enterocyte-like phenotype and serves as a model for intestinal epithelial cells [29] . We cultured Caco-2 cells in low-glucose DMEM supplemented with 10% FBS, 100 U/mL penicillin and 100 μg/mL streptomycin at 37 °C under a 7% CO2 atmosphere for 28 days as we previously described [30] (link). The medium was changed every 2 days, and the cells were incubated in serum-free DMEM for 24 h before all experiments. Dimethyl sulfoxide (DMSO) was the control vehicle, and the solvent (final concentration 0.1% v/v) for microcystin-LR, SP600125, rifampicin, and probenecid.
+ Open protocol
+ Expand
2

Establishment and Maintenance of Cell Lines

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human cervical carcinoma HeLa (RCB0007), hepatoma HepG2 (RCB1648), colon carcinoma Caco-2 (RCB0988), embryonic kidney 293T (RCB2202), and mouse myoblast C2C12 (RCB0987) cells were obtained from Riken Cell Bank (Tsukuba, Japan). Human embryonic kidney 293 (JCRB9068), rat hepatoma Fao (89042701), and rat cardiomyocyte H9c2 (CRL-1446) cells were obtained from Japanese Collection of Research Bioresources (JCRB) Cell Bank (National Institutes of Biomedical Innovation, Health and Nutrition, Osaka, Japan), ECACC (Salisbury, UK), and ATCC (Manassas, VA, USA), respectively. These cells were maintained in Eagle’s minimum essential medium (MEM, FUJIFILM Wako Pure Chemical Corporation) containing antibiotics and 10% fetal bovine serum, except for C2C12 and H9c2 cells, which were maintained in Dulbecco’s modified Eagle medium (FUJIFILM Wako Pure Chemical Corporation). Primary cultured rat cardiomyocytes (CMC02) were obtained from COSMO BIO (Tokyo, Japan).
+ Open protocol
+ Expand
3

Caco-2 Cell Monolayer for Transepithelial Permeability

Check if the same lab product or an alternative is used in the 5 most similar protocols
The human colonic adenocarcinoma epithelial cell line Caco-2 was obtained from Riken Cell Bank (Ibaraki, Japan) and kept in a humidified incubator at 37°C with 5% CO2. Caco-2 cells were maintained in Dulbecco's Modified Eagle Medium (DMEM)-High glucose (Wako, Osaka, Japan) supplemented with 10% heat-inactivated (30 min, 56°C) fetal bovine serum (Biowest, Nuaillé, France), 100 U/mL penicillin, 100 μg/mL streptomycin, and 1% nonessential amino acids (NEAA) (Wako). In this study, Caco-2 cells were used between passages 25 and 40. Cells cultivated to 80% confluence were seeded on 12-well Transwell® inserts (1.12 cm2 polycarbonate membrane with 0.4 μm pore size; Corning Life Sciences, Corning, NY) at a density of 5 × 104 cells per well. The culture medium was changed every 2 days until 20 days later when full polarization of the Caco-2 cell monolayer was achieved. The integrity of the Caco-2 cell monolayer was evaluated by measuring the transepithelial electrical resistance (TER) using a milicell-ERS (Millipore, Billerica, MA). The TER values measured in the experiments were summarized as table form below each figure, and all the figures were expressed as the relative TER value compared to the value before experimental treatment.
+ Open protocol
+ Expand
4

Cell Culture Conditions for Common Cell Lines

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human lung adenocarcinoma cells (A549), human epidermoid carcinoma cells (A431), human epithelial colorectal adenocarcinoma cells (Caco-2), African green monkey kidney cells (Vero), and Madin-Darby canine kidney epithelial cells (MDCK) were obtained from Riken Cell Bank (Tsukuba, Japan). Cells were cultivated in DMEM containing 10% fetal calf serum (FCS), streptomycin (100 μg/ml), penicillin (100 U/ml), and glutamine (2 mM) (FCS-DMEM). All culture steps were performed at 37°C in 5% CO2.
+ Open protocol
+ Expand
5

Culturing Human Cell Lines for Research

Check if the same lab product or an alternative is used in the 5 most similar protocols
We cultured human embryonic kidney 293 cells and 4 human colorectal cancer cell lines (DLD-1, Caco-2, LoVo, and HT-29) in specific culture media. 293, Caco-2, and LoVo cells were obtained from RIKEN Cell Bank (RIKEN BRC, Tsukuba, Japan). DLD-1 cells were from the American Type Culture Collection (Manassas, VA). HT-29 cells were from Sumitomo Pharma Co., Ltd. (Osaka, Japan). We cultured the 293 and DLD-1 cells in Dulbecco’s Modified Eagle’s Minimum Essential Medium (Catalog number 08456–65, Nacalal Tesque, Kyoto, Japan) supplemented with 10% fetal bovine serum (FBS) and 100 μg/ml kanamycin. We cultured Caco-2 cells in minimum essential medium (Catalog number M4655, Sigma–Aldrich, St. Louis, MO) supplemented with 20% FBS, 0.1 mM Non-Essential Amino Acids (Catalog number M7145, Sigma–Aldrich), and 100 μg/ml kanamycin. We cultured the LoVo cells in Ham’s F-12 media (Catalog number N6658, Sigma–Aldrich) supplemented with 10% FBS and 100 μg/ml kanamycin and cultured the HT-29 cells in McCoy's 5a modified medium (Catalog number 16600082, Thermo Fisher Scientific) supplemented with 10% FBS and 100 μg/ml kanamycin.
+ Open protocol
+ Expand
6

Cell Culture Protocol for Colon Cancer Cell Lines

Check if the same lab product or an alternative is used in the 5 most similar protocols
LoVo, Colo-205, Caco-2, and Colon-26 cells were obtained from the Riken Cell Bank (Ibaraki, Japan) and maintained in RPMI-1640 medium (Sigma, St Louis, MO, USA) and fetal bovine serum (FBS; Gibco, Carlsbad, CA, USA) in the presence of 5% CO2 at 37 °C. SW948 cells were obtained from the Japanese Collection of Research Bioresources (Osaka, Japan) and maintained in L-15 medium (Sigma) supplemented with FBS (Gibco) in the presence of 5% CO2 at 37 °C. HT-29 cells were purchased from DS Pharma Biomedical (Osaka, Japan) and maintained in McCoy’s 5a medium (Sigma) supplemented with FBS (Gibco) in the presence of 5% CO2 and temperature at 37 °C. L-OHP was purchased from LC Laboratories (Woburn, MA, USA). Simvastatin and fluvastatin were obtained from FUJIFILM Wako (Tokyo, Japan).
+ Open protocol
+ Expand
7

Cell Culture Conditions for Drug-Resistant Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
DLD-1 cells were purchased from the Health Science Research Resources Bank (Osaka, Japan). LoVo, Colo-205 and Caco-2 cells were purchased from Riken Cell Bank (Ibaraki, Japan). HT-29 cells were purchased from DS Pharma Biomedical (Osaka, Japan). These cells were cultured in RPMI1640 medium (Sigma, St Louis, MO, USA), HamF12 medium (Sigma) or McCoy’s 5A medium (Sigma) supplemented with 10% fetal bovine serum (Gibco, Carlsbad, CA, USA), 100 μg/mL penicillin (Gibco), 100 U/mL streptomycin (Gibco) and 25 mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (pH 7.4; FUJIFLIM Wako, Tokyo, Japan) in an atmosphere containing 5% CO2.
LoVo and Colo-205 cells with acquired resistance to PD0325901 (LC Laboratories, Woburn, MA, USA) or trametinib (LC Laboratories) (LoVo/PR, Colo-205/PR and LoVo/TR) were generated as previously described [37 (link),51 (link),52 (link),53 (link),54 (link),55 (link)].
+ Open protocol
+ Expand
8

Caco-2 Cell Culture Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
The epithelial cell line Caco-2 was obtained from the RIKEN Cell Bank (Tsukuba, Japan). The cells were cultured in Dulbecco’s modified Eagle’s medium (Sigma-Aldrich, St. Louis, Missouri) supplemented with 10% (v/v) fetal bovine serum, 10 U/mL penicillin, and 10 μg/mL streptomycin. The cells were maintained in 25-cm2 flasks and then seeded onto eight-chamber glass slides (Fukaekasei and Watson, Hyogo, Japan). The cells were then grown to confluence for 10 days at 37 °C in the presence of 5% CO2, and the medium was changed every two days.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!